Cargando…

Renin Angiotensin System Inhibition as treatment for Covid-19?

Detalles Bibliográficos
Autor principal:	Williams, Professor Bryan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8275567/ https://www.ncbi.nlm.nih.gov/pubmed/34278280 http://dx.doi.org/10.1016/j.eclinm.2021.101023

Ejemplares similares

Renin-angiotensin system blockers and COVID-19
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2021)

Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19
por: Williams, Bryan, et al.
Publicado: (2020)

Commentary to Angiotensin-Converting-Enzyme 2 and Renin–Angiotensin System Inhibitors in COVID-19: An Update
por: Ferri, Claudio, et al.
Publicado: (2021)

Renin-angiotensin system inhibitors in hospitalised patients with COVID-19
por: Williams, Bryan
Publicado: (2021)

Angiotensin-converting enzyme 2 and new insights into the renin–angiotensin system
por: Lambert, Daniel W., et al.
Publicado: (2008)

The interaction between the endocannabinoid system and the renin angiotensin system and its potential implication for COVID-19 infection
por: Sainz-Cort, Alberto, et al.
Publicado: (2020)

Renin-angiotensin system inhibition in COVID-19 patients
por: de Vries, A. A. F.
Publicado: (2020)

Renin-angiotensin-aldosterone system and kidney interactions in heart failure
por: Ferreira, João Pedro, et al.
Publicado: (2019)

COVID-19 and the Renin-Angiotensin System
por: Malha, Line, et al.
Publicado: (2020)

Is It Time to Rethink the Age-Old Practice of Permissive Hyperkalemia in Renin-Angiotensin-Aldosterone Inhibition?
por: Ambruso, Sophia L.
Publicado: (2021)

The systemic renin-angiotensin system in COVID-19
por: Reindl-Schwaighofer, Roman, et al.
Publicado: (2022)

Renin–angiotensin system inhibition in COVID-19 patients: Friend or foe?
por: Karadağ, Bilgehan
Publicado: (2020)

Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic
por: South, Andrew M., et al.
Publicado: (2020)

COVID-19, Renin-Angiotensin System, and Hematopoiesis
por: Çiftçiler, Rafiye, et al.
Publicado: (2020)

The renin angiotensin aldosterone system and COVID-19
por: Alsufyani, Hadeel A., et al.
Publicado: (2020)

Renin Angiotensin System and COVID-19 Infection
por: Ferrara, Francesco, et al.
Publicado: (2022)

Drugs Modulating Renin-Angiotensin System in COVID-19 Treatment
por: Labandeira-Garcia, Jose L., et al.
Publicado: (2022)

The Modulatory Action of Vitamin D on the Renin–Angiotensin System and the Determination of Hepatic Insulin Resistance
por: Leung, Po Sing
Publicado: (2019)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

Improvement of Sodium Status to Optimize the Efficacy of Renin-Angiotensin System Blockade
por: Laverman, Gozewijn D., et al.
Publicado: (2011)

Why the renin–angiotensin–aldosterone system (RAAS) in critically ill patients can no longer be ignored
por: Zarbock, Alexander, et al.
Publicado: (2021)

Use of Renin-Angiotensin System Blockers During the COVID-19 Pandemic: Early Guidance and Evolving Evidence
por: Turgeon, Ricky D., et al.
Publicado: (2020)

Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19
por: Lu, Ling, et al.
Publicado: (2020)

Renin-angiotensin system at the interface of COVID-19 infection
por: Gul, Rukhsana, et al.
Publicado: (2021)

Covid-19, hypokalaemia and the renin-angiotensin-aldosterone system
por: Mandal, Amit.K.J., et al.
Publicado: (2021)

Renin–angiotensin system blockade in the COVID-19 pandemic
por: Cohen, Jordana B, et al.
Publicado: (2021)

Quantifying Renin-Angiotensin-System Alterations in COVID-19
por: Pucci, Fabrizio, et al.
Publicado: (2021)

COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
por: Amraei, Razie, et al.
Publicado: (2020)

Covid-19: the renin–angiotensin system imbalance hypothesis
por: Lanza, Katharina, et al.
Publicado: (2020)

Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19
por: Jarcho, John A., et al.
Publicado: (2020)

Renin-angiotensin-aldosterone system and COVID-19 infection
por: Alexandre, Joachim, et al.
Publicado: (2020)

Renin-angiotensin system at the heart of COVID-19 pandemic
por: Alifano, Marco, et al.
Publicado: (2020)

Renin–Angiotensin System Implications to COVID-19 Comorbidities
por: Alsufyani, Hadeel A., et al.
Publicado: (2020)

What’s new in the renin-angiotensin system?: What’s new in the renin-angiotensin system?
por: Smith, A. I., et al.
Publicado: (2004)

Downregulation of ACE2 induces overstimulation of the renin–angiotensin system in COVID-19: should we block the renin–angiotensin system?
por: Silhol, François, et al.
Publicado: (2020)

Nocebo affects after COVID-19 vaccination
por: Sever, Professor Peter
Publicado: (2021)

The role of renin angiotensin system inhibition in kidney repair
por: van der Meer, Irene M, et al.
Publicado: (2010)

Repositioning of pentoxifylline as an immunomodulator and regulator of the renin-angiotensin system in the treatment of COVID-19
por: Maldonado, Valente, et al.
Publicado: (2020)

COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?
por: Zores, Florian, et al.
Publicado: (2020)

COVID‐19 and renin angiotensin aldosterone system: Pathogenesis and therapy
por: Babajani, Fatemeh, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nhl6b7qrli2jpcn1vs1fljnb9q